Alcon Inc. - Registered Shares
ALC
Market Cap$42.8B
Close$
Earnings Call Q3 2024
November 13, 2024 - AI Summary
Strong Third Quarter Performance: Alcon reported third quarter sales of $2.4 billion, a 6% increase year-over-year (YOY), and core diluted earnings per share of $0.81, marking a 25% growth. The core operating margin improved to 20.6%, reflecting operational efficiency.
Guidance Adjustments: The company updated its full-year revenue guidance to $9.8 billion - $9.9 billion, reflecting a decrease from previous expectations. The lowered outlook is attributed to softness in the U.S. surgical market and operational challenges, indicating a slowing competitive landscape in certain segments.
Free Cash Flow Records: Alcon generated a record $1.3 billion in free cash flow over the first nine months of the year, significantly up from $592 million in the previous year, highlighting strong operational cash generation which could support future investments.
Exclusive for Stockcircle Pro members
Sign up
$10.52
87.9% downside
Current Fair Value
87.9% downsideOvervalued by 87.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $42.80 Billion |
|---|---|
| Enterprise Value | $41.23 Billion |
| Dividend Yield | $0.27 (0.304760258183495%) |
| Earnings per Share | $1.98 |
| Beta | 0.73 |
| Outstanding Shares | 494,600,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 36.96 |
|---|---|
| PEG | 127.8 |
| Price to Sales | 4.34 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 4.16 |
| Enterprise Value to EBIT | 27.6 |
| Enterprise Value to Net Income | 35 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Alcon, Inc.
20,000 employees
CEO: David J. Endicott Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the followi...